Merck’s Sugammadex Surgery Drug Hits Another Snag

The FDA has issued Merck a complete response letter for sugammadex sodium injection after canceling an advisory committee meeting earlier this summer to discuss the drug. Merck is seeking approval of the drug to be used to reverse neuromuscular blockade induced by rocuronium or vecuronium, drugs used to relax muscles during surgery.
Washington Drug Letter